Literature DB >> 12805426

High-frequency genetic recombination and reactivation of orthopoxviruses from DNA fragments transfected into leporipoxvirus-infected cells.

Xiao-Dan Yao1, David H Evans.   

Abstract

Poxvirus DNA is not infectious because establishing an infection requires the activities of enzymes packaged in the virion. This barrier can be overcome by transfecting virus DNA into cells previously infected with another poxvirus, since the resident virus can provide the trans-acting systems needed to reactivate transfected DNA. In this study we show that cells infected with a leporipoxvirus, Shope fibroma virus (SFV), can reactivate vaccinia virus DNA. Similar heterologous packaging systems which used fowlpox-infected cells to reactivate vaccinia virus have been described, but SFV-infected cells promoted a far more efficient reaction that can produce virus titers exceeding 10(6) PFU/ micro g of transfected DNA. SFV-promoted reactions also exploit the hyperrecombinogenic systems previously characterized in SFV-infected cells, and these coupled recombination and reactivation reactions could be used to delete nonessential regions of the vaccinia virus genome and to reconstruct vaccinia virus from overlapping DNA fragments. SFV-catalyzed recombination reactions need only two 18- to 20-bp homologies to target PCR amplicons to restriction enzyme-cut vaccinia virus vectors, and this reaction feature was used to rapidly clone and express a gene encoding fluorescent green protein without the need for plaque purification or selectable markers. The ability of SFV-infected cells to reactivate fragments of vaccinia virus was ultimately limited by the number of recombinational exchanges required and one cannot reconstruct vaccinia virus from multiple PCR fragments spanning essential portions of the genome. These observations suggest that recombination is an integral part of poxvirus reactivation reactions and provide a useful new technique for altering the structure of poxvirus genomes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12805426      PMCID: PMC164822          DOI: 10.1128/jvi.77.13.7281-7290.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  Effects of DNA structure and homology length on vaccinia virus recombination.

Authors:  X D Yao; D H Evans
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Construction of recombinant vaccinia viruses using PUV-inactivated virus as a helper.

Authors:  T M Timiryasova; B Chen; N Fodor; I Fodor
Journal:  Biotechniques       Date:  2001-09       Impact factor: 1.993

3.  The reactivation of poxviruses. I. Demonstration of the phenomenon and techniques of assay.

Authors:  W K JOKLIK; G M WOODROOFE; I H HOLMES; F FENNER
Journal:  Virology       Date:  1960-05       Impact factor: 3.616

4.  Heteroduplex DNA formation is associated with replication and recombination in poxvirus-infected cells.

Authors:  C Fisher; R J Parks; M L Lauzon; D H Evans
Journal:  Genetics       Date:  1991-09       Impact factor: 4.562

5.  A glutaredoxin, encoded by the G4L gene of vaccinia virus, is essential for virion morphogenesis.

Authors:  C L White; A S Weisberg; B Moss
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

6.  Targeted construction of temperature-sensitive mutations in vaccinia virus by replacing clustered charged residues with alanine.

Authors:  D E Hassett; R C Condit
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

7.  Transcription of viral late genes is dependent on expression of the viral intermediate gene G8R in cells infected with an inducible conditional-lethal mutant vaccinia virus.

Authors:  Y Zhang; J G Keck; B Moss
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

8.  Nonreplicating vaccinia vector efficiently expresses recombinant genes.

Authors:  G Sutter; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

9.  Construction of chimeric vaccinia viruses by molecular cloning and packaging.

Authors:  F Scheiflinger; F Dorner; F G Falkner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

10.  Cloning the vaccinia virus genome as a bacterial artificial chromosome in Escherichia coli and recovery of infectious virus in mammalian cells.

Authors:  Arban Domi; Bernard Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-26       Impact factor: 11.205

View more
  20 in total

1.  Marker rescue mapping of the combined Condit/Dales collection of temperature-sensitive vaccinia virus mutants.

Authors:  Sayuri E M Kato; Nissin Moussatche; Susan M D'Costa; Travis W Bainbridge; Cindy Prins; Audra L Strahl; Amber N Shatzer; Alyson J Brinker; Nicole E Kay; Richard C Condit
Journal:  Virology       Date:  2008-03-07       Impact factor: 3.616

2.  Phenotypic analysis of a temperature sensitive mutant in the large subunit of the vaccinia virus mRNA capping enzyme.

Authors:  Amber N Shatzer; Sayuri E M Kato; Richard C Condit
Journal:  Virology       Date:  2008-03-04       Impact factor: 3.616

3.  Vaccinia H5 is a multifunctional protein involved in viral DNA replication, postreplicative gene transcription, and virion morphogenesis.

Authors:  Susan M D'Costa; Travis W Bainbridge; Sayuri E Kato; Cindy Prins; Karen Kelley; Richard C Condit
Journal:  Virology       Date:  2010-03-05       Impact factor: 3.616

4.  Introduction of the six major genomic deletions of modified vaccinia virus Ankara (MVA) into the parental vaccinia virus is not sufficient to reproduce an MVA-like phenotype in cell culture and in mice.

Authors:  Christine Meisinger-Henschel; Michaela Späth; Susanne Lukassen; Michael Wolferstätter; Heike Kachelriess; Karen Baur; Ulrike Dirmeier; Markus Wagner; Paul Chaplin; Mark Suter; Jürgen Hausmann
Journal:  J Virol       Date:  2010-07-28       Impact factor: 5.103

5.  Poxviruses as Gene Therapy Vectors: Generating Poxviral Vectors Expressing Therapeutic Transgenes.

Authors:  Steven J Conrad; Jia Liu
Journal:  Methods Mol Biol       Date:  2019

Review 6.  Killing a killer: what next for smallpox?

Authors:  Grant McFadden
Journal:  PLoS Pathog       Date:  2010-01-29       Impact factor: 6.823

7.  Genome scale patterns of recombination between coinfecting vaccinia viruses.

Authors:  Li Qin; David H Evans
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

8.  The vaccinia virus E8R gene product is required for formation of transcriptionally active virions.

Authors:  Sayuri E M Kato; Richard C Condit; Nissin Moussatché
Journal:  Virology       Date:  2007-07-09       Impact factor: 3.616

9.  An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge.

Authors:  Guang Yang; Daniel C Pevear; Marc H Davies; Marc S Collett; Tom Bailey; Susan Rippen; Linda Barone; Chris Burns; Gerry Rhodes; Sanjeev Tohan; John W Huggins; Robert O Baker; R L Mark Buller; Erin Touchette; Kem Waller; Jill Schriewer; Johan Neyts; Erik DeClercq; Kevin Jones; Dennis Hruby; Robert Jordan
Journal:  J Virol       Date:  2005-10       Impact factor: 6.549

10.  An efficient method for generating poxvirus recombinants in the absence of selection.

Authors:  Amanda D Rice; Stacey A Gray; Yu Li; Inger Damon; Richard W Moyer
Journal:  Viruses       Date:  2011-03       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.